Guidelines for efficient peripheral blood progenitor cell collection

Area of Science:

• Hematology
• Oncology
• Cellular Therapy

Background:

• Peripheral blood progenitor cells (PBPC) are increasingly utilized for hematopoietic recovery post-chemotherapy.
• Leukopheresis is the method for collecting PBPC after mobilization with chemotherapy or growth factors.

Purpose of the Study:

• To highlight the importance of efficient PBPC mobilization and precise leukopheresis timing.
• To discuss the assessment of mobilization efficiency and the need for established threshold values.
• To explore the role of CD34+ selection in purging tumor cells and reducing relapse rates.

Main Methods:

• Mobilization of PBPC using chemotherapy and/or hematopoietic growth factors.
• Leukopheresis for PBPC collection.
• Cell assays and FACS analysis to assess mobilization efficiency.
• CD34+ selection for apheresis products.

Main Results:

• Efficient mobilization and timely leukopheresis minimize the number of procedures needed for adequate PBPC collection.
• Mobilization efficiency is influenced by multiple factors.
• Target values for rapid hematological reconstitution exist, but thresholds for specific conditions require further establishment.
• CD34+ selection aids in tumor cell purging and may reduce relapse rates in malignancies.

Conclusions:

• Optimizing PBPC collection strategies is vital for effective cancer treatment.
• Further research is needed to define optimal collection thresholds for diverse clinical scenarios.
• CD34+ selection offers potential benefits for reducing relapse in both solid tumors and hematological malignancies.